Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05979714 · ClinicalTrials.gov registry record · NA

The Cheeky Study: A Novel Delivery System for CAB-RPV LA

A NA study of HIV Infections, sponsored by Public Health Foundation Enterprises.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05979714 is a NA study of HIV Infections that is active but no longer recruiting, run by Public Health Foundation Enterprises. The registered enrollment target is 50 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05979714, a NA study of HIV Infections, is active but no longer recruiting, sponsored by Public Health Foundation Enterprises.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a single-arm implementation study of a novel integrated delivery model of CAB-RPV LA for transwomen living with HIV.

Conditions Studied

Interventions

  • OTHER Patient-centered injection site
  • BEHAVIORAL Patient-centered adherence support
  • OTHER Provider education
  • BEHAVIORAL Improved clinic communication strategies

Study Locations (1)

California

  • Bridge HIV, San Francisco Department of Public Health - San Francisco

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-05-31
Est. Completion 2024-12
Phase NA

What the Registry Record Tells You About NCT05979714

The ClinicalTrials.gov registry entry for NCT05979714 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (89% lower). The listed sponsor is Public Health Foundation Enterprises, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 4 interventions - of which Patient-centered injection site is the first listed.

NCT05979714 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05979714 about?

NCT05979714 is a clinical study titled "The Cheeky Study: A Novel Delivery System for CAB-RPV LA". This is a single-arm implementation study of a novel integrated delivery model of CAB-RPV LA for transwomen living with HIV.

What is the current status of trial NCT05979714?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-05-31. Estimated completion is 2024-12.

What conditions does trial NCT05979714 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT05979714?

The interventions under investigation include: Patient-centered injection site (OTHER), Patient-centered adherence support (BEHAVIORAL), Provider education (OTHER), Improved clinic communication strategies (BEHAVIORAL).

Who is sponsoring clinical trial NCT05979714?

This trial is sponsored by Public Health Foundation Enterprises, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05979714 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.